
|Articles|December 1, 2002
Supplements and Featured Publications
- Immune-Mediated Inflammatory Disorders (I.M.I.D.s): A New Concept in Medical Care
- Volume 8
- Issue 21 Suppl
Immune-Mediated Inflammatory Disorders (I.M.I.D.s): The Economic and Clinical Costs
Advertisement
Articles in this issue
about 23 years ago
Participating Facultyabout 23 years ago
CME/CPE QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
Making the Genetic Models Match the Ancestry of Patient Populations
3
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5














































